Outlining the EANM Guidance Document: Dosimetry for First-in-human Studies & Early Phase Clinical Trials
Time: 9:30 am
day: Conference Day Two
Details:
- Exploring different emitters and carrier molecules
- Outlining methods for activity measurement, pharmacokinetic analyses, as well as absorbed dose calculations and uncertainty analyses
- Discussing the optimal use of preclinical information and studies involving diagnostic analogues
